Showing results (691-700 of 5,681) with videos related to
Sort By:
Pageof 569
The Oncologist|April 19, 2002
Comparable efficacy of epoetin alfa for anemic cancer patients receiving platinum- and nonplatinum-based chemotherapy: a retrospective subanalysis of two large, community-based trialsJohn Glaspy, Laurent Degos, Mario Dicato, et al.The Oncologist|April 19, 2002
Osteogenic sarcoma presenting with lung metastasisArthur P Staddon, Richard Lackman, Keith Robinson, et al.The Oncologist|April 19, 2002
Molecular targets of arsenic trioxide in malignant cellsWilson H MillerThe Oncologist|April 19, 2002
Nontraditional cytotoxic therapies for relapsed/refractory multiple myelomaMohamad A HusseinThe Oncologist|November 3, 2005
Preclinical perspectives on bisphosphonate renal safetyJean-Jacques Body, Thomas Pfister, Frieder BaussThe Oncologist|November 3, 2005
Efficacy of ibandronate in metastatic bone disease: review of clinical dataRichard BellThe Oncologist|November 10, 2009
Long-term outcomes in stage IIIB breast cancer patients who achieved less than a pathological complete response (<pCR) after primary chemotherapyMaria Teresa Ionta, Francesco Atzori, Maria Cristina Deidda, et al.The Oncologist|October 27, 2005
Hematologic safety and tolerability of topotecan in recurrent ovarian cancer and small cell lung cancer: an integrated analysisDeborah K Armstrong, David Spriggs, Jeremey Levin, et al.The Oncologist|October 27, 2005
Combined therapy with weekly irinotecan, infusional 5-fluorouracil and the selective COX-2 inhibitor rofecoxib is a safe and effective second-line treatment in metastatic colorectal cancerGiampietro Gasparini, Domenico Gattuso, Alessandro Morabito, et al.Pageof 569